KCI Biotech is a leading inflammation CRO providing comprehensive research solutions for inflammatory and immune system diseases. We specialize in developing and validating CRO inflammation models that accurately mimic human pathophysiology.
Our immunology CRO services support pharmaceutical and biotechnology clients in drug discovery, mechanism exploration, and efficacy evaluation across key indications. Each study is conducted under GLP-compliant conditions, ensuring data quality, reproducibility, and scientific integrity throughout every project stage.
KCI Biotech offers a broad portfolio of preclinical models to meet diverse CRO for immunology research needs. We provide validated inflammation CRO services across multiple species, covering a spectrum of autoimmune and inflammatory conditions.
Model of type II collagen-induced rheumatoid arthritis
Adjuvant-induced rheumatoid arthritis models
Model of rheumatoid arthritis induced by yeast zymosan A (ZIA)Non-human primate model of spontaneous rheumatoid arthritis
Model of dextran sulfate (DSS)-induced inflammatory bowel disease
Model of trinitrobenzene sulfonic acid (TNBS)-induced inflammatory bowel disease
Oxazolone (OXA)-induced inflammatory bowel disease model
Acetic acid-induced inflammatory bowel disease model
MRL/MpJ-Faslpr mouse model of systemic lupus erythematosus
Septicemia model of cecal filtrate infection
Model of septicemia induced by ligation and puncture of the cecum (CLP)
Dermatomyositis induced by myosin Fuchsin complete adjuvant combined with pertussis toxin
Dermatomyositis induced by myosin Fuchsin complete adjuvant in combination with B. pertussis toxin
Each model is validated with reproducible biomarkers, histopathological characteristics, and quantifiable efficacy endpoints, ensuring translational relevance for human clinical applications.
KCI Biotech is an immunology and inflammation CRO with deep expertise in immunology preclinical CRO services. We integrate pharmacology, immunology, and pathology to support the CRO for immunology drug development, from early discovery to IND-enabling studies.
We operate two AAALAC-accredited, GLP-aligned animal facilities (over 40,000 m²). Our platforms are designed to support all types of in vivo immunology and inflammation research, ensuring robust data and regulatory readiness.
With 1,000+ collaborations and 100+ IND submissions, KCI Biotech is a trusted inflammation and immunology CRO. Our experience streamlines study design, regulatory strategy, and translational data interpretation for global partners.
We tailor every study based on compound characteristics and clinical goals. Our professional inflammation CRO services ensure each project is scientifically rigorous, cost-efficient, and delivered on time.
From model selection to data interpretation, KCI Biotech’s immunology CRO services help bridge the gap between basic research and clinical success. Whether your focus is on RA, IBD, lupus, or septicemia, our expertise accelerates the path toward safer and more effective therapies.
Partner with us to transform your immunology discovery into clinical success. For more information about our inflammation CRO services, please contact us today.
Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china
